A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 4, 2006, Pages 408-413

  Komeno, Yukiko ^a   Kanda, Yoshinobu ^a   Hamaki, Tamae ^b   Mitani, Kinuko ^c   Iijima, Kimiko ^b   Ueyama, Jun Ichi ^d   Yoshihara, Satoshi ^b   Yuji, Koichiro ^d   Kim, Sung Won ^b   Ando, Toshihiko ^b   Kami, Masahiro ^b   Yamamoto, Emi ^e   Hiruma, Kiyoshi ^f   Mori, Shin Ichiro ^b   Hirai, Hisamaru ^a   Sakamaki, Hisashi ^f  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d TORANOMON HOSPITAL   (Japan)

^e TOKYO METROPOLITAN BOKUTOH HOSPITAL   (Japan)

^f TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Filgrastim; Granulocyte colony stimulating factor; Mobilization; Peripheral blood stem cell transplantation; Randomized controlled trial

Indexed keywords

CD34 ANTIGEN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE; AGED; APHERESIS; ARTICLE; BONE PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DONOR SELECTION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; LEUKOCYTE COUNT; MALE; MULTICENTER STUDY; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX; STATISTICAL SIGNIFICANCE; STEADY STATE; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD DONORS; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED;

EID: 33644908300     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.11.007     Document Type: Article

References (21)

1. L.B. To D.N. Haylock P.J. Simmons et al. The biology and clinical uses of blood stem cells Blood 89 1997 2233-2258
2. Stem Cell Trialists' Collaborative Group Allogeneic peripheral blood stem cell compared with bone marrow transplantation in the management of hematologic malignancies an individual patient data meta-analysis of nine randomized trials J Clin Oncol 23 2005 5074-5087
3. S.D. Rowley G. Donaldson K. Lilleby et al. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation Blood 97 2001 2541-2548
4. M. Engelhardt H. Bertz M. Afting et al. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection J Clin Oncol 17 1999 2160-2172
5. M. Korbling D. Przepiorka Y.O. Huh et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma potential advantage of blood over marrow allografts Blood 85 1995 1659-1665
6. C.H. Weaver R. Birch F.A. Greco et al. Mobilization and harvesting of peripheral blood stem cells: Randomized evaluations of different doses of filgrastim Br J Haematol 100 1998 338-347
7. W. Zeller K. Gutensohn M. Stockschlader et al. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis Bone Marrow Transplant 17 1996 709-713
8. N. Russel A. Gratwohl N. Schmitz The place of blood stem cells in allogeneic transplantation Br J Haematol 93 1996 747-753
9. C. Arbona F. Prosper I. Benet et al. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation Bone Marrow Transplant 22 1998 39-45
10. N. Kröger W. Zeller H.T. Hassan et al. Schedule-dependency of granulocyte colony-stimulating factor in peripheral blood progenitor cell mobilization in breast cancer patients Blood 91 1998 1828
11. P. Anderlini M. Donato M.J. Lauppe et al. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors Br J Haematol 109 2000 770-772
12. N. Kroger H. Renges W. Kruger et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation Br J Haematol 111 2000 761-765
13. B. Spilker Guide to Clinical Trials 1991 Raven Press New York
14. P. Anderlini D. Przepiorka Y. Huh et al. Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation Br J Haematol 93 1996 940-942
15. J. de la Rubia C. Arbona F. de Arriba et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors Transfusion 42 2002 4-9
16. T. Demirer W.I. Bensinger Optimization of peripheral blood stem cell collection Curr Opin Hematol 2 1995 219-226
17. G. Miflin C. Charley C. Stainer et al. Stem cell mobilization in normal donors for allogeneic transplantation: Analysis of safety and factors affecting efficacy Br J Haematol 95 1996 345-348
18. P. Anderlini D. Przepiorka C. Seong et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim Transfusion 37 1997 507-512
19. Y. Gazitt Q. Liu High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34+ PBSC in patients undergoing high-dose chemotherapy and stem cell rescue J Hematother Stem Cell Res 9 2000 285-293
20. R. Bellucci M.S. De Propris F. Buccisano et al. Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF Bone Marrow Transplant 23 1999 1-8
21. R. Mohle S. Murea M. Kirsch et al. Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery Exp Hematol 23 1995 1535-1542